# WAINUA (AUTOINJECTOR)
> **NDA217388** · New Drug Application · Sponsor: ASTRAZENECA AB · Approved 2023-12-21
## Drug
- **FDA Application Number:** NDA217388
- **Application type:** New Drug Application
- **Brand name:** WAINUA (AUTOINJECTOR)
- **Generic name:** EPLONTERSEN
- **Active ingredients:** EPLONTERSEN SODIUM
- **Dosage form:** SOLUTION
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** ASTRAZENECA AB
- **Manufacturer:** AstraZeneca Pharmaceuticals LP
- **First approval:** 2023-12-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217388)
---
*AI Analytics · CC0 1.0*